Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

61.3K
Overview
61.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

718
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
718
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

322
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
322
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

285
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

268
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
268

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A single-cell isolation strategy for screening diverse functional Haloarchaea strains.

Journal of microbiological methods·2026
Same author

A novel <i>de novo QRICH1</i> variant causing Ververi-Brady syndrome with infantile epileptic spasms syndrome: clinical and genetic analysis.

Frontiers in neuroscience·2026
Same author

Leveraging longitudinal data to boost statistical power for gene-environment interaction analysis.

Nature computational science·2026
Same author

Metagenomics-guided targeted isolation and mechanistic elucidation of haloalkaliphilic bisphenol A-degrading microorganisms.

Bioresource technology·2026
Same author

PROTAC-mediated PCSK9 degradation attenuates atherosclerosis and improves plaque composition via suppression of NF-κB/TNF-α pathway.

BMC medicine·2026
Same author

Image restoration model compression via mamba-oriented heterogeneous knowledge distillation.

Neural networks : the official journal of the International Neural Network Society·2026

Related Experiment Video

Updated: Jan 3, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
10:07

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

68.1K

Macrophage polarization in atherosclerosis.

Sai Yang1, Hou-Qin Yuan1, Ya-Meng Hao1

  • 1Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerosis of Hunan Province, University of South China, Hengyang City, Hunan Province, 421001, PR China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|November 16, 2019
PubMed
Summary

Regulating macrophage polarization offers a novel therapeutic strategy for atherosclerosis. Modifying macrophage phenotypes within plaques can reduce plaque size and improve stability, aiding cardiovascular disease treatment.

Keywords:
AtherosclerosisMacrophage polarizationPhenotype

More Related Videos

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
07:45

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Published on: November 28, 2015

36.4K
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
07:42

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

Published on: June 12, 2013

19.4K

Related Experiment Videos

Last Updated: Jan 3, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
10:07

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

68.1K
Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
07:45

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Published on: November 28, 2015

36.4K
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
07:42

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

Published on: June 12, 2013

19.4K

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pathogenesis of Atherosclerosis

Background:

  • Atherosclerosis is a chronic inflammatory condition linked to cardiovascular diseases.
  • Macrophage polarization and phenotype are critical to atherosclerosis development and progression.
  • Understanding macrophage roles is key to treating atherosclerotic cardiovascular disease.

Purpose of the Study:

  • To review the intricate relationship between macrophage polarization and atherosclerosis.
  • To explore therapeutic strategies targeting macrophage polarization in atherosclerosis treatment.
  • To provide a new perspective on atherosclerosis therapy by focusing on macrophage modulation.

Main Methods:

  • Literature review on macrophage polarization in atherosclerosis.
  • Analysis of studies investigating the impact of macrophage phenotypes on plaque development.
  • Synthesis of research on therapeutic interventions targeting macrophage polarization.

Main Results:

  • Macrophage polarization significantly influences the pathogenesis of atherosclerosis.
  • The balance of macrophage phenotypes within atherosclerotic plaques affects disease severity.
  • Modulating macrophage polarization has shown potential in reducing plaque size and enhancing plaque stability.

Conclusions:

  • Regulating macrophage polarization presents a promising therapeutic avenue for atherosclerosis.
  • Targeting macrophage phenotypes offers a novel approach to managing atherosclerotic cardiovascular disease.
  • Future research should focus on translating macrophage polarization modulation into clinical treatments.